✦ LIBER ✦

In vitro models of multiple system atrophy

✍ Scribed by Nadia Stefanova; Markus Reindl; Werner Poewe; Gregor K. Wenning

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 85 KB
Volume: 20
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20540

No coin nor oath required. For personal study only.

✦ Synopsis

alpha-Synuclein represents the major constituent of oligodendroglial cytoplasmic inclusions, the hallmark lesion of multiple system atrophy (MSA), a progressive disorder that is associated with selective degenerative cell loss in basal ganglia, cerebellum, brainstem, and spinal cord. The role of abnormal alpha-synuclein aggregation in oligodendroglial cells is still obscure, in particular, whether alpha-synuclein might impair oligodendroglial and, secondarily, neuronal integrity of those cells in the diseased brain. In an attempt to answer some of these questions, we have developed an "in vitro model of MSA" by expressing the wild-type or C-terminally truncated form of alpha-synuclein in glial cell cultures. With this simplified system, we have demonstrated that alpha-synuclein significantly affects the survival of glia and its vulnerability to environmental stress, which might represent a major step in the pathogenesis of MSA.

📜 SIMILAR VOLUMES

In vivo models of multiple system atroph

In vivo models of multiple system atrophy

✍ Pierre-Olivier Fernagut; Imad Ghorayeb; Elsa Diguet; François Tison 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Multiple system atrophy (MSA) is a sporadic adult-onset neurodegenerative disorder of unknown etiology clinically characterized by a combination of parkinsonian, pyramidal, and cerebellar signs. Levodopa-unresponsive parkinsonism is present in 80% of MSA cases, and this dominant clinical presentatio

Survival in multiple system atrophy

✍ Anette Schrag; Gregor K. Wenning; Niall Quinn; Yoav Ben-Shlomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eighty‐five of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twenty‐four patients came to autopsy, which showed MSA

Therapeutic strategies in multiple syste

Therapeutic strategies in multiple system atrophy

✍ Gregor K. Wenning; Felix Geser; Werner Poewe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

This review provides an update on therapeutic principles and their implications for practical management in multiple system atrophy (MSA), a sporadic neurodegenerative disorder characterized clinically by various combinations of dysautonomia, Parkinsonism, or cerebellar ataxia, often associated with

Facial myokymia in multiple system atrop

Facial myokymia in multiple system atrophy

✍ Dr. S. B. Blunt; N. M. Khalil; G. D. Perkin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

## Abstract Two patients are described with clinical and neuroimaging features consistent with a diagnosis of multiple system atrophy (MSA). The patients are unusual in that facial myokymia became apparent clinically at some stage in their illness. In each patient, the nature and severity of the in

Olivopontocerebellar pathology in multip

Olivopontocerebellar pathology in multiple system atrophy

✍ G. K. Wenning; F. Tison; L. Elliott; N. P. Quinn; Dr. S. E. Daniel 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

## Abstract Olivopontocerebellar atrophy (OPCA) is widely accepted as part of the neuropathological spectrum of multiple system atrophy (MSA). The distribution of affected sites in the olivopontocerebellar (OPC) system and their interrelationship remain poorly understood due to lack of quantitative

Olfactory bulb in multiple system atroph

Olfactory bulb in multiple system atrophy

✍ Tibor Kovács; Mátyás I. Papp; Nigel J. Cairns; M. Nadeem Khan; Peter L. Lantos 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

## Abstract Olfactory dysfunction is a characteristic clinical sign in Parkinson's disease (PD); it is also present in multiple system atrophy (MSA). The pathological basis of hyposmia or anosmia in PD is well known: the olfactory bulb (OB) contains numerous Lewy bodies and severe neuronal loss is